obsessive-compulsive%20disorder
OBSESSIVE-COMPULSIVE DISORDER
Obsessive-compulsive disorder is characterized by the presence of either obsessions or compulsions, but more commonly by both symptoms that can cause marked impairment or distress.
Obsession is a recurrent, persistent, intrusive, unwanted thought, image or urge that cause distressing emotions (eg anxiety and disgust).
Compulsion is a repetitive behavior or mental act that the person feels driven to perform, in order to lessen the distress caused by the obsession.
Anxiety is the central feature of obsessive-compulsive disorder.

Multidisciplinary Review

Multidisciplinary Team

  • With expertise in obsessive-compulsive disorder & referred to when treatment options fail to produce adequate response
  • Supports & collaborates with those professionals already involved in the patient’s care

Recommendations after Multidisciplinary Review

  • Combination therapy with cognitive-behavioral therapy & selective serotonin reuptake inhibitors for patients with inadequate response to selective serotonin reuptake inhibitors alone within 12 weeks or cognitive-behavioral therapy of >10 therapist hours per patient
  • Another selective serotonin reuptake inhibitors or Clomipramine should be offered for patients with inadequate response to combined treatment of selective serotonin reuptake inhibitors & cognitive-behavioral therapy, no response to selective serotonin reuptake inhibitor alone, or have not engaged with cognitive-behavioral therapy
  • Clomipramine should be considered after an adequate trial of at least one selective serotonin reuptake inhibitor which has been ineffective or poorly tolerated, patient prefers Clomipramine, or has good response previously to Clomipramine
  • Other options if there are no response after a full trial of at least 1 selective serotonin reuptake inhibitor alone, combination therapy with cognitive-behavioral therapy & selective serotonin reuptake inhibitor, & Clomipramine alone
    • Additional cognitive-behavioral therapy
    • Additional antipsychotic to a selective serotonin reuptake inhibitor or Clomipramine
    • Combine Clomipramine & Citalopram

Monitoring

  • Frequency of visits will depend on the severity of the symptoms, complexities of co-occurring conditions, presence of suicidal ideation, & side effects
  • Psychotherapy should be done as often as necessary

Follow Up

  • Follow-up visit is done a few days to 2 weeks after the initiation of therapy
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 3 days ago
Treatment with oral thrombopoietin receptor agonist eltrombopag leads to similar platelet counts in patients with chronic immune thrombocytopaenia (cITP) and persistent (per)ITP, according to the results of phase III (EXTEND) and IV studies presented at the 23rd Congress of the European Hematology Association (EHA 2018) held in Stockholm, Sweden.
Pearl Toh, 5 days ago
Lonely people were twice as likely to die from any cause than people who did not feel lonely, according to a study based on a national survey presented at the recent EuroHeartCare 2018 in Dublin, Ireland. Also, loneliness is associated with poorer patient-reported outcomes in terms of mental and physical health in patients with heart disease.
Jairia Dela Cruz, 3 days ago
A treatment regimen combining daratumumab plus bortezomib, melphalan and prednisone markedly extends progression-free survival in patients with multiple myeloma, inducing deep responses and demonstrating acceptable tolerability regardless of baseline renal function, according to the results of the phase III ALCYONE study.
Yesterday
Segmentectomy and lobectomy confer similar overall survival (OS) and lung cancer-specific survival (LCSS) among patients with primary nonsmall cell lung cancer (NSCLC) of ≤20 mm without lymph node or distant metastasis, a recent study has shown.